Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00741195
Recruitment Status : Completed
First Posted : August 26, 2008
Last Update Posted : October 4, 2016
Information provided by (Responsible Party):
Hellenic Oncology Research Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2016
  Study Completion Date : October 2016